ATE493404T1 - Azabicyclo-(3,1,0)-hexan-derivate als modulatoren von dopamin-d3-rezeptoren - Google Patents
Azabicyclo-(3,1,0)-hexan-derivate als modulatoren von dopamin-d3-rezeptorenInfo
- Publication number
- ATE493404T1 ATE493404T1 AT06791503T AT06791503T ATE493404T1 AT E493404 T1 ATE493404 T1 AT E493404T1 AT 06791503 T AT06791503 T AT 06791503T AT 06791503 T AT06791503 T AT 06791503T AT E493404 T1 ATE493404 T1 AT E493404T1
- Authority
- AT
- Austria
- Prior art keywords
- group
- 4alkyl
- haloc1
- 4alkoxy
- 4alkanoyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Reproductive Health (AREA)
- Psychiatry (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0507680.7A GB0507680D0 (en) | 2005-04-15 | 2005-04-15 | Compounds |
PCT/EP2006/003778 WO2006136223A1 (en) | 2005-04-15 | 2006-04-13 | Azabicyclo (3.1.0) hexane derivatives useful as modulators of dopamine d3 receptors |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE493404T1 true ATE493404T1 (de) | 2011-01-15 |
Family
ID=34630768
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT06791503T ATE493404T1 (de) | 2005-04-15 | 2006-04-13 | Azabicyclo-(3,1,0)-hexan-derivate als modulatoren von dopamin-d3-rezeptoren |
Country Status (8)
Country | Link |
---|---|
US (1) | US7875643B2 (de) |
EP (1) | EP1871768B1 (de) |
JP (1) | JP5231992B2 (de) |
AT (1) | ATE493404T1 (de) |
DE (1) | DE602006019221D1 (de) |
ES (1) | ES2358445T3 (de) |
GB (1) | GB0507680D0 (de) |
WO (1) | WO2006136223A1 (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT2060570E (pt) * | 2004-02-23 | 2012-05-07 | Glaxo Group Ltd | Derivados de azabiciclo(3.1.0)-hexano úteis como moduladores dos receptores d3 da dopamina |
GB0507601D0 (en) * | 2005-04-14 | 2005-05-18 | Glaxo Group Ltd | Compounds |
GB0507602D0 (en) * | 2005-04-14 | 2005-05-18 | Glaxo Group Ltd | Compounds |
ATE484502T1 (de) * | 2005-06-14 | 2010-10-15 | Glaxo Group Ltd | Neue verbindungen |
GB0512099D0 (en) * | 2005-06-14 | 2005-07-20 | Glaxo Group Ltd | Compounds |
KR20170005888A (ko) | 2005-07-27 | 2017-01-16 | 뉴로반스, 인크. | 신규 1-아릴-3-아자바이사이클로[3.1.0]헥산:제조 방법 및 신경 정신 질환 치료를 위한 용도 |
GB0517191D0 (en) | 2005-08-22 | 2005-09-28 | Glaxo Group Ltd | Compounds |
GB0517175D0 (en) * | 2005-08-22 | 2005-09-28 | Glaxo Group Ltd | Compounds |
EP1919908B1 (de) * | 2005-08-22 | 2010-11-10 | Glaxo Group Limited | Triazolderivate als modulatoren von dopamin-d3-rezeptoren |
GB0517193D0 (en) * | 2005-08-22 | 2005-09-28 | Glaxo Group Ltd | Novel use |
GB0517187D0 (en) * | 2005-08-22 | 2005-09-28 | Glaxo Group Ltd | Compounds |
US8163927B2 (en) * | 2006-04-03 | 2012-04-24 | Glaxo Group Limited | Azabicyclo [3.1.0] hexane derivatives as modulators of dopamine D3 receptors |
WO2007113260A1 (en) * | 2006-04-03 | 2007-10-11 | Glaxo Group Limited | Azabicyclo [3. 1. o] hexyl derivatives as modulators of dopamine d3 receptors |
FR2953521B1 (fr) * | 2009-12-09 | 2011-11-18 | Servier Lab | Nouveaux derives azabicyclo[3.1.0]hex-2-yl, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
NZ739139A (en) | 2015-08-05 | 2023-01-27 | Indivior Uk Ltd | Dopamine d3 receptor antagonists having a bicyclo moiety |
WO2019146740A1 (ja) | 2018-01-26 | 2019-08-01 | 塩野義製薬株式会社 | ドーパミンd3受容体拮抗作用を有する環式化合物 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4425144A1 (de) * | 1994-07-15 | 1996-01-18 | Basf Ag | Triazolverbindungen und deren Verwendung |
AR022229A1 (es) * | 1999-01-12 | 2002-09-04 | Abbott Gmbh & Co Kg | Compuestos de triazol, composicion farmaceutica que los comprende y uso de los mismos para preparar dicha composicion |
GB0015562D0 (en) | 2000-06-23 | 2000-08-16 | Pfizer Ltd | Heterocycles |
ATE382617T1 (de) | 2000-11-14 | 2008-01-15 | Smithkline Beecham Plc | Tetrahydrobenzazepin-derivate zur verwendung als dopamin-d3-rezeptor-modulatoren (antipsychotische mittel) |
PT2060570E (pt) | 2004-02-23 | 2012-05-07 | Glaxo Group Ltd | Derivados de azabiciclo(3.1.0)-hexano úteis como moduladores dos receptores d3 da dopamina |
GB0507601D0 (en) * | 2005-04-14 | 2005-05-18 | Glaxo Group Ltd | Compounds |
GB0512099D0 (en) * | 2005-06-14 | 2005-07-20 | Glaxo Group Ltd | Compounds |
EP1919908B1 (de) * | 2005-08-22 | 2010-11-10 | Glaxo Group Limited | Triazolderivate als modulatoren von dopamin-d3-rezeptoren |
-
2005
- 2005-04-15 GB GBGB0507680.7A patent/GB0507680D0/en not_active Ceased
-
2006
- 2006-04-13 ES ES06791503T patent/ES2358445T3/es active Active
- 2006-04-13 EP EP06791503A patent/EP1871768B1/de active Active
- 2006-04-13 US US11/911,229 patent/US7875643B2/en not_active Expired - Fee Related
- 2006-04-13 WO PCT/EP2006/003778 patent/WO2006136223A1/en active Application Filing
- 2006-04-13 DE DE602006019221T patent/DE602006019221D1/de active Active
- 2006-04-13 AT AT06791503T patent/ATE493404T1/de not_active IP Right Cessation
- 2006-04-13 JP JP2008505844A patent/JP5231992B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP5231992B2 (ja) | 2013-07-10 |
US20080167357A1 (en) | 2008-07-10 |
ES2358445T3 (es) | 2011-05-10 |
EP1871768B1 (de) | 2010-12-29 |
EP1871768A1 (de) | 2008-01-02 |
US7875643B2 (en) | 2011-01-25 |
JP2008535888A (ja) | 2008-09-04 |
WO2006136223A1 (en) | 2006-12-28 |
DE602006019221D1 (de) | 2011-02-10 |
GB0507680D0 (en) | 2005-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE493404T1 (de) | Azabicyclo-(3,1,0)-hexan-derivate als modulatoren von dopamin-d3-rezeptoren | |
ATE487715T1 (de) | Triazolderivate als modulatoren von dopamin-d3- rezeptoren | |
ATE484502T1 (de) | Neue verbindungen | |
DE602006006850D1 (de) | Als modulatoren von dopamin-d3-rezeptoren geeignete azabicyclo-(3,1,0)-hexan-derivate | |
GB0507601D0 (en) | Compounds | |
NO20064309L (no) | Azabicyklo(3.1.0)heksanderivater anvendelige som modulatorer for dopamin D3 receptorer | |
PE20070212A1 (es) | Heterociclos de 1,4-dihidropiridina-condensados, procesos para preparar los mismos, uso y composiciones que los contienen | |
AR077935A1 (es) | Derivados de 3-amino-5 fenil-5,6-dihidro-2h-(1,4)oxazina | |
MX2007007103A (es) | Derivados espiro como inhibidores de lipoxigenasa. | |
DE602006006712D1 (de) | Thiazolylpiperidin-derivate nützlich als h3 rezeptor modulatoren | |
BRPI0515412A (pt) | composto, composição farmacêutica, e, uso de um composto ou uma composição farmacêutica | |
NO20076479L (no) | Nye oksadiazolderivater og anvendelse derav som positive allosteriske metabotropiske modulatorer av glutamatreseptorer | |
EA200901160A1 (ru) | Производные 3-циано-4-(4-тетрагидропиранфенил)пиридин-2-она | |
EA200901159A1 (ru) | Производные 3-циано-4-(4-фенилпиперидин-1-ил)пиридин-2-она | |
PE20110028A1 (es) | Derivados de isoxazol y su uso como potenciadores de los receptores metabotropicos de glutamato | |
TW200716531A (en) | Cyclohexanesulfonyl derivatives as GLYT1 inhibitors to treat schizophrenia | |
UY29312A1 (es) | Piperazin-1-carboxamidas n,4,sustituidas y sus derivados, composiciones que los contienen, procedimientos de preparación y aplicaciones | |
EA201101566A1 (ru) | Производные имидазола и их применение в качестве модуляторов циклинзависимых киназ | |
BRPI0418368A (pt) | derivados de (3-oxo-3,4-dihidro-quinoxalin2-ilamino)-benzamida e compostos afins, como inibidores de glicogênio fosforilase para o tratamento de diabetes e obesidade | |
ATE420859T1 (de) | Azabicycloä3.1.0ühexylphenylderivate als modulatoren von dopamin-d3-rezeptoren | |
PE20091436A1 (es) | Derivados de sulfonamidas sustituidas como moduladores b1r | |
AR072809A1 (es) | Compuesto de (3- piridinilcarbonil)-4-(fenilsulfonilpiperazina ), su uso para la elaboracion de unmedicamento para el tratamiento del dolor y composicion farmaceutica que lo comprende | |
CY1112679T1 (el) | Κινολινες και θεραπευτικη χρηση αυτων | |
PE20080191A1 (es) | Compuestos heterociclicos apropiados para tratar trastornos que responden a la modulacion del receptor de serotonina 5ht6 | |
ATE512142T1 (de) | Pyrimidin- und chinazolinderivate als modulatoren der somatostatin-rezeptor aktivität |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |